Some of AstraZeneca’s most successful products have been drugs like Prilosec and Nexium, Crestor, Onglyza, Farxiga, and more. For medical enquiries about our products (including questions on how to take your medicine, to report a side effect or make a complaint regarding one of our medicines). Our range is targeted at meeting important patient needs in areas such as: cancer, cardiovascular, diabetes, gastrointestinal, neuroscience, respiratory and inflammation. The Director will develop strategic partnerships and innovation for marketed and late-stage products through creative thinking and ideation that transcends traditional pharmaceutical marketing and sales approaches. Please find below a list of  AstraZeneca Product discontinuations within the last 2 years. © AstraZeneca 2021. Seroquel 100mg                                   Â, Seroquel 200mg                                   Â, Seroquel 300mg                                   Â, Seroquel XL 50mg                                Â. You can help by reporting any side effects you may get. AstraZeneca are not responsible for the content or privacy / legal policies of any third party websites. Find below a list of AstraZeneca Product recalls within the past 6 months. Working with government and policy makers, Medical and Educational Goods and Services, AZ Medical and Educational Goods and Services in Diabetes, AZ Medical and Educational Goods and Services in Asthma. We publish information about the registration and results of all new and ongoing clinical trials for all products in all phases on our dedicated website. We also have a Global and other country sites; click the links in 'Other AstraZeneca websites' for the directory. Cardiovascular and metabolic diseases are complex and require life-long attention. Visit the AstraZeneca … AstraZeneca provides this link as a service to website visitors. This website is intended for doctors, nurses, and pharmacists in the UK. With more than $24 billion in revenue in 2019 and 70,600 employees, the Cambridge-based drugmaker continues to rank among the largest drug companies in the world. AstraZeneca has a track record of pharmaceutical innovation that spans 60 years and includes the introduction of many world leading medicines. By Phone: 1-800-668-6000 (English), 1-800-461-3787 (French) Monday - Friday 8 a.m. - 5 p.m. (EST), excluding holidays. VVPM ID: GB-20010 Date of Prep: December 2019. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. AstraZeneca has been driving cardiovascular innovation for more than 100 years. AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. At AstraZeneca we share a common purpose: to push the boundaries of science to deliver life-changing medicines. Patients need to address many factors — from preventive measures, to care at the onset of disease to ongoing disease management. If you have any questions or experience any side effects while taking an AstraZeneca medication, please contact us as noted below. At the time of analysis, 23,745 participants ≥18 years old had been randomised and received either COVID-19 Vaccine AstraZeneca or control. Heart disease or coronary artery disease (CAD) is a chronic and persistent condition in which the arteries that supply the heart with blood are narrowed. We are advancing a pipeline of inhaled and biologic treatments, drug combinations and devices, and other therapies that aim to transform disease management. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. We find creative ways to approach new challenges. The company’s purpose and values include following science and putting patients first. The patient-centric approach is reinforced by science-led life-cycle management programs and technologies, including early research into regenerative methods. The website contains both promotional and non-promotional content. We’re curious about science and the advancement of knowledge. We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel, targeted therapies that interact with them. AstraZeneca's strategy in CVMD focuses on ways to reduce morbidity, mortality and organ damage by addressing multiple risk factors across cardiovascular (CV) disease, diabetes and chronic kidney-disease indications. Our enduring goal is to push the boundaries of science to further reduce cardiovascular morbidity and mortality beyond current treatments, and to deliver transformative cardiovascular medicines … We aim to save the lives of people who suffer from cardiovascular disease, heart failure and diabetes, by driving solutions that break with conventional thinking. Important notice for users Our focus is on the following: Cardiovascular, Renal and Metabolism; Oncology; Respiratory. The Packing centre, packs a wide range of key Pharmaceutical products for the European, Middle East and Asia regions (EMEA). We have a strong pipeline with more than 33,000 patients participating in Phase I-IV respiratory clinical trials across the world. In spite of the huge successes and billions of dollars in revenue, this huge pharmaceutical company has had major setbacks. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. AstraZeneca from time to time takes the decision to divest a product from its portfolio. AstraZeneca provides this link as a service to our site visitors. In 2019, AstraZeneca invested more than $145 million in Canadian health sciences research in our core therapy areas. You are about to access AstraZeneca historic archive material. Life at AstraZeneca. All rights reserved. Other UK residents please visit astrazeneca.co.uk. US: EU: Japan: China: Additional information: Partnered product. Adverse events should also be reported to AstraZeneca on 0800 783 0033 and via https://aereporting.astrazeneca.com Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. Alternatively, you can report any side effects of prescription drugs directly to the FDA. AstraZeneca has a track record of pharmaceutical innovation that spans 60 years and includes the … Our focus is on the following core therapy areas: Cardiovascular, Renal and Metabolic diseases (CVRM); Oncology; and Respiratory & Immunology. All pharmacologically effective drugs have benefits and risks. Adverse events should be reported. AstraZeneca Canada was named one of Canada’s 10 Most Admired Cultures in 2020 by Waterstone Human Capital – a national … Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033. Molecule size: Combination molecule. Imfinzi + RT (platform) CLOVER - Phase I. AstraZeneca has been developing cancer medicines for more than 40 years. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Online: https://aereporting.astrazeneca.com/home.html We encourage you to read the privacy policy of every website you visit. In 2017, our respiratory medicines reached more than 18 million patients. The risk may be insignificant or may be acceptable in relation to the drug's therapeutic action. Outside these hours and on bank holidays, an out of hours service is available to assist with urgent enquiries. This will allow quick identification of new safety information. You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. Komboglyze® (saxagliptin/metformin hydrochloride), Vimovo® (naproxen/esomeprazole magnesium), Zestoretic® (lisinopril dehydrate/hydrochlorothiazide). Even as R&D continues to push boundaries in how we understand and fight cancer, there is still more to do. AstraZeneca has a portfolio of products for major diseases including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation areas.. 01/07/20                         Â, 56044756SH                       Â, 01/07/20                       Â, 5608475XSH                      Â, 01/07/20                        Â, 5631475XSH                       Â, 5637475XSH                      Â, 01/07/20                     Â, 5634475XSH                      Â, Seroquel XL 300mg                              Â, 5635475XSH                      Â, 5636475XSH                      Â, Zomig 2.5mg  Tablets  1 x6’s with wallet, Zomig Rapimelt 5mg  1 x 6’s with wallet, Calquence▼ Cap 100mg BL 10 x 6 EA GB, Trixeo Aerosphere 160/7.2/5.0MCG PMDI 1X120D. In such circumstances individual patients may be eligible for early access to an AstraZeneca investigational medicinal product. This website is intended for people seeking information on AstraZeneca's UK business. AstraZeneca’s recent THALES Phase III trial has demonstrated the efficacy of the drug Brilinta for reducing the risk of major cardiovascular events such as heart attacks, strokes, or cardiovascular deaths. Please contact our UK based Medical Information team. This report shows the current availability of our products. Reporting forms and information can be found at  www.mhra.gov.uk/yellowcard. See www.mhra.gov.uk/yellowcard for how to report side effects. AstraZeneca has introduced many world leading medicines. If you are experiencing problems obtaining AstraZeneca products please contact our Supply Chain team by phone: 0800 783 0033 (option 1) or email: [email protected]. We supply multiple products which support our key therapeutic areas of Cardiovascular and Oncology. Cardiovascular, Renal and Metabolism (CVRM) - AstraZeneca Cardiovascular, Renal and Metabolism (CVRM) We aim to save the lives of people who suffer from cardiovascular disease, heart failure, chronic kidney disease and diabetes, by advancing CVRM solutions and addressing shared risk factors between these distinct but interrelated disease areas AstraZeneca plc (/ ˌ æ s t r ə ˈ z ɛ n ə k ə /) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters in Cambridge, England. Lines are open from Monday-Friday, 9am - 5pm. We provide details of new and ongoing clinical trials sponsored by AstraZeneca. Please refer to your approved national product label (SmPC) for … Respiratory is one of AstraZeneca’s three main therapy areas. Please use Google Chrome 52.0 or Internet Explorer 11 or later. Our goal at AstraZeneca is to reduce the high cost of long-term complications with comprehensive support programs and resources that provide a thoughtful, personalized approach. is recognised as world leading due to our ability to manufacture key Sterile Parenteral products. Adverse events should also be reported to AstraZeneca on 0800 783 0033 and via https://aereporting.astrazeneca.com. Our range is targeted at meeting important patient needs in areas such as: cancer, cardiovascular, diabetes, gastrointestinal, neuroscience, respiratory and inflammation. AstraZeneca is not responsible for the privacy policy of any third party websites. Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed. Apologies for any inconvenience. AstraZeneca has pushed the boundaries of science and helped millions of patients with respiratory disease. 4,5 Atherosclerotic plaque, a build-up of deposits of fatty material, cholesterol, cellular waste products and other substances, accumulate in the coronary arteries, obstructing the blood flow to the heart muscle. If you are experiencing problems obtaining AstraZeneca products please call 0800 783 0033 (option 1). By email: medinfo.Canada@astrazeneca.com. AstraZeneca is an international biopharmaceutical company that produces and markets medicines used by millions of people around the world. Our modern and simplified supply and delivery service ensures that all community pharmacies, dispensing doctors and hospitals will have the right medicine, delivered to the right place, for every patient, every time. AstraZeneca are committed to meeting patient needs through innovative medicines and clinical excellence, we conduct clinical trials to help determine the safety and efficacy of a new medicine. By reporting side effects you can help provide more information on the safety of this medicine. This includes any possible side effects not listed in the package leaflet. Adverse events should be reported. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088. As a Cardiovascular Metabolic (CVMD) Clinical Science Liaison, you'll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients' lives. Please visit our careers site to find more information. We’re driven to make the right choices and be accountable for our actions. I have read this warning and will not be using any of the contained product information for clinical purposes. In line with our Group Corporate Responsibility Policy on transparency, we are committed to open communication of information on AstraZeneca's clinical trials. Nous croyons que la meilleure façon d’aider les patients consiste à prioriser les percées scientifiques en vue de mettre au jour ces mécanismes et d’élaborer de nouvelles thérapies ciblées qui interagiront avec eux. Unfortunately, you are using an unsupported browser. The content on this website is intended for UK Healthcare Professionals only. ▼ This medicine is subject to additional monitoring. Continuous monitoring of the safety of a drug throughout the duration of its use helps to ensure that its risks and benefits remain acceptable. The overall safety of COVID-19 Vaccine AstraZeneca is based on an interim analysis of pooled data from four clinical trials conducted in the United Kingdom, Brazil, and South Africa. We recognise that there are circumstances where patients with serious or life-threatening diseases have exhausted all available therapeutic options and may not be eligible to enrol in one of our clinical trials. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. There are no further AZ product recalls to report. This simply means that the Marketing Authorisation of the product transfers to another company who then take ownership of the supply of the product. As an organisation centred around what makes us human, we put a big focus on people. Real World Experience with BRILIQUE from key experts, Dr Hussain Contractor - P2Y12 inhibitors improve ACS survival, Dr Yahya Al-Najjar - The high-risk post-myocardial infarction (MI) patient pathway, Professor Ahmet Fuat - Long-term management of high-risk post-MI patients, Professor Rick Body - Acute Coronary Syndrome (ACS) Diagnosis - The Future, Dr Marc Bonaca - Approaches to patient selection for long-term DAPT, Patient information leaflets and materials. Status change: Imfinzi + RT (platform) CLOVER locally-advanced head and neck squamous cell carcinoma, non-small cell lung cancer, small-cell lung cancer. Please refer to your approved national product label (SmPC) for … AstraZeneca’s FARXIGA® was granted Breakthrough Therapy Designation (BTD) in the U.S. for Chronic Kidney Disease, following the DAPA-CKD Phase III trial results in which the drug showed an unprecedented reduction in the risk of kidney failure and cardiovascular or renal death in patients with chronic kidney disease, the company announced on Friday. We address shared risk factors between these distinct but interrelated disease areas and view patients holistically and not according to indication. 5 The plaque can cause a partial or complete blockage … Early access to AstraZeneca investigational medicinal products. Many of these have increased survival rates for patients in the UK and around the world. Please find below AstraZeneca's recently launched products: This link will take you to a website not owned by AstraZeneca. In order to monitor the safety of AstraZeneca products, we encourage reporting any side effects experienced while taking an AstraZeneca product to the AZ Information Center at 1-800-236-9933. Please find below a list of AstraZeneca Product divestments within the last 2 years. Please refer to your approved national product label (SmPC) for current product information. If you get any side effects, talk to your doctor, pharmacist or nurse.